We may well be on a cross purpose , the Phase I is hugely Valuable ,, 1st it showed that MPL was Tolerable and Soluble and a beneficial dose could make it across the Blood Brain Barrier , that beneficial dose obviously had a positive effect on a Degenerative Disease MND.
Its the level of statistics gathered from only 12 Patients ,,, is that enough to satisfy the FDA to make an informed decision to approve MPL "Pharmapantel" for global use?
Well we are all about to find out,,,very soon...NZT
On the funding the ASX regulation is the Company must have 2 X Q operating Capital , so funds must be raised and banked in the next 77 days.
We may well be on a cross purpose , the Phase I is hugely...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.5¢ | 21.0¢ | $325.8K | 1.512M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 236217 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 78289 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.005 ( 2.23 %) |
||||
| Open | High | Low | Volume | ||
| 21.5¢ | 22.5¢ | 21.0¢ | 629786 | ||
| Last updated 15.58pm 03/06/2024 ? | |||||
| PAA (ASX) Chart |